Regulus Therapeutics
RGLS
#6949
Rank
NZ$0.97 B
Marketcap
NZ$14.12
Share price
0.00%
Change (1 day)
446.62%
Change (1 year)

P/S ratio for Regulus Therapeutics (RGLS)

P/S ratio on December 6, 2025 (TTM) : N/A

According to Regulus Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.18. At the end of 2025 the company had a P/S ratio of N/A.

P/S ratio history for Regulus Therapeutics from 2012 to 2025

PS ratio at the end of each year

Year P/S ratio Change
2025N/A
2024N/A
2023N/A
2022N/A
2021N/A-100%
20208.57212.92%
20192.74-97.6%
2018114-92.41%
2017> 10001405.64%
201699.7350.77%
201522.1-78.39%
2014102548.71%
201315.8-11.22%
201217.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
GlaxoSmithKline
GSK
2.30N/A๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
2.54N/A๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
2.66N/A๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.81N/A๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
18.8N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
5.11N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.22N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA